Tender detail
Non-exclusive rebate agreement for Tolvaptan
Summary
The tender concerns a non-exclusive rebate agreement for the medicinal product Tolvaptan (only strength 7.5 mg, pack size N2) for the period 01/07/2026 to 30/06/2028, with an option to extend once by 12 months. DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible. The machine-readable notice did not include precise qualification, exclusion or compliance requirements; these must be checked in the tender documents.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.